1. Home
  2. HAIN vs MREO Comparison

HAIN vs MREO Comparison

Compare HAIN & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hain Celestial Group Inc. (The)

HAIN

Hain Celestial Group Inc. (The)

HOLD

Current Price

$0.49

Market Cap

53.7M

ML Signal

HOLD

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

HOLD

Current Price

$0.35

Market Cap

50.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAIN
MREO
Founded
1993
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.7M
50.3M
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
HAIN
MREO
Price
$0.49
$0.35
Analyst Decision
Hold
Buy
Analyst Count
9
5
Target Price
★ $2.23
$1.50
AVG Volume (30 Days)
1.5M
★ 1.6M
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 42.95
16.67
EPS
N/A
★ N/A
Revenue
★ $2,457,769,000.00
$500,000.00
Revenue This Year
N/A
$5,184.20
Revenue Next Year
N/A
$55.51
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.48
$0.20
52 Week High
$1.69
$2.37

Technical Indicators

Market Signals
Indicator
HAIN
MREO
Relative Strength Index (RSI) 34.18 66.87
Support Level N/A $0.31
Resistance Level $0.64 $0.35
Average True Range (ATR) 0.06 0.02
MACD -0.02 0.01
Stochastic Oscillator 4.03 82.55

Price Performance

Historical Comparison
HAIN
MREO

About HAIN Hain Celestial Group Inc. (The)

The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas, among others. It operates under two reportable segments: North America and International. The majority of its revenue is derived from the North America segment, which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Share on Social Networks: